Sun Jian David Sells Shares of 111, Inc. (YI)

Sun Jian David sold 115,440 shares of 111, Inc., valued at $25,396.80, on June 10, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 2:01 PM EDT

Key Points

Sun Jian David sold 115,440 shares of 111, Inc. valued at $25,396.80 on June 10, 2026.
Shares of 111, Inc. traded near $4.57 with a market cap of $40.2 million and a forward P/E of 32.64.
Peer funds like Renaissance Technologies and Serenus Wealth Advisors also adjusted their holdings in 111, Inc.

Sun Jian David, an insider at 111, Inc. (NasdaqGM: YI), sold 115,440 shares of the company on June 10, 2026. The transaction was valued at $25,396.80, with shares priced at $0.22 each. This sale was not part of a pre-planned trading program.

Other Institutional Activity in 111, Inc.

Several institutional investors have also been active in 111, Inc. Renaissance Technologies LLC increased its holdings by 300 shares, bringing its total to 13,014 shares valued at about $84,851. Serenus Wealth Advisors, LLC trimmed its position by 64 shares, ending with 4,320 shares worth around $321,334. Meanwhile, Citigroup Inc. added 207 shares, reaching a total of 207 shares valued at $1,341.

111, Inc. Stock Snapshot

Shares of 111, Inc. are trading near $4.57 on the NasdaqGM. The company has a market cap of approximately $40.2 million. Its forward P/E ratio stands at 32.64, indicating potential future earnings. The stock has a 52-week low of $2.48 and a high of $11.17. The 50-day moving average is $5.88, while the 200-day moving average is $5.40. The company has a current ratio of 1.08 and a quick ratio of 0.37, with a debt-to-equity ratio of 150.93.

Insider Buying and Selling at 111, Inc.

In addition to Sun Jian David's recent sale, other insiders were active. On June 15, 2026, Sun Jian David sold another 58,800 shares at $0.23 per share. Chen Yang Luke also sold shares on the same day, offloading 44,000 shares at $0.23 each. Earlier, on June 12, 2026, Chen Yang Luke sold 49,920 shares at the same price.

About 111, Inc.

111, Inc. operates a hybrid online and offline platform in China's healthcare market. It focuses on supply chain integration for pharmaceutical companies, offering services like product promotion and customer analytics. The company's online wholesale and retail pharmacies provide a wide range of health and wellness products. Headquartered in Shanghai, it was founded in 2010 and is led by CEO Mr. Junling Liu. 111, Inc. has around 1,063 employees.

Bottom Line

Sun Jian David's recent share sale is a notable insider transaction at 111, Inc. Investors often watch insider sales for potential insights into company sentiment. However, it's important to remember that these transactions may not always indicate future company performance. As always, 13F filings and insider reports are backward-looking and may not reflect current positions.